| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | CERO | Common Stock | 50,000 | 14 Feb 2024 | Direct |
Exhibit 24 - Power of Attorney. Effective immediately after the Effective Time as defined in that certain Business Combination Agreement dated as of June 4, 2023, as amended, by and among the Issuer (f/k/a Phoenix Biotech Acquisition Corp.), CERo Therapeutics, Inc., and PBCE Merger Sub, Inc. (the "Business Combination Agreement"), the reporting person was elected as a member of the board of directors of the Issuer.